$59.07

(%)
Live
Previous Close

$59.07

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

None

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

TORONTO and CHICAGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that Ken d’Entremont, Chief Executive Officer of Medexus, and Marcel Konrad, Chief Financial Officer of Medexus, will be participating in two upcoming virtual investor conferences.

Related tickers: MDP.

Read Full Article

NDA resubmission expected in second calendar quarter 2022 (previously anticipated timeline)Final FDA decision expected 2 to 6 months after NDA resubmissionNo additional Phase III study is required

Related tickers: MDP.

Read Full Article
Trending Tickers

Please sign in to view